We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

216 hedge funds and large institutions have $2.23B invested in Select Medical in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 68 increasing their positions, 93 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

6.84% more ownership

Funds ownership: 142.14%148.98% (+6.8%)

8% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 25

0% less funds holding

Funds holding: 217216 (-1)

5% less capital invested

Capital invested by funds: $2.36B → $2.23B (-$127M)

27% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 93

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

96% less call options, than puts

Call options by funds: $15K | Put options by funds: $428K

Holders
216
Holders Change
-1
Holders Change %
-0.46%
% of All Funds
3.72%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
27
Increased
68
Reduced
93
Closed
25
Calls
$15K
Puts
$428K
Net Calls
-$413K
Net Calls Change
-$481K

SEM Hedge Fund Activity: Q3 2022 in Review

216 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q3 2022, worth a combined $2.23B — down 5.4% from $2.36B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new SEM positions and 25 closed out — a net gain of 2 holders — while 68 added to existing stakes and 93 trimmed.

The largest buyer was Invesco, adding an estimated $33.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $94M.

  • 216 institutional investors held Select Medical (SEM) as of Q3 2022, down from 217 in Q2 2022.
  • Funds reported $2.23B of Select Medical stock for Q3 2022, down 5.4% quarter-over-quarter.
  • 27 funds opened new Select Medical positions in Q3 2022 and 25 closed out, a net change of +2 holders.
  • The largest Select Medical buyer in Q3 2022 was Invesco, an estimated $33.3M added.
  • The largest Select Medical seller in Q3 2022 was T. Rowe Price Associates, an estimated $94M sold.

Based on aggregated 13F filings for Q3 2022.